Alendronat 1A Pharma may be available in the countries listed below.
Ingredient matches for Alendronat 1A Pharma
Alendronic Acid is reported as an ingredient of Alendronat 1A Pharma in the following countries:
- Slovakia
International Drug Name Search
Alendronat 1A Pharma may be available in the countries listed below.
Alendronic Acid is reported as an ingredient of Alendronat 1A Pharma in the following countries:
International Drug Name Search
Wokadine may be available in the countries listed below.
Povidone-Iodine is reported as an ingredient of Wokadine in the following countries:
International Drug Name Search
Reducing the amount of phosphorus in the blood in patients with chronic kidney disease who are on dialysis.
Renvela Powder Packets are a phosphate binder. It works by binding with phosphate in the digestive tract, which decreases the amount of phosphate absorbed into the body.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Renvela Powder Packets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Renvela Powder Packets. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Renvela Powder Packets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Renvela Powder Packets as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Renvela Powder Packets.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Constipation; diarrhea; gas; indigestion; mild stomach pain; nausea; vomiting.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); severe or persistent constipation or stomach pain.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Renvela side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Store Renvela Powder Packets at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store in a tightly closed container. Store away from heat, moisture, and light. Do not store in the bathroom. Do not use after the expiration date. Keep Renvela Powder Packets out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Renvela Powder Packets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Starpod-Kid may be available in the countries listed below.
Cefpodoxime is reported as an ingredient of Starpod-Kid in the following countries:
International Drug Name Search
Ceruletide Diethylamine may be available in the countries listed below.
Ceruletide Diethylamine (BANM, USAN) is also known as Ceruletide (Rec.INN)
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |